www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm263366.pdf ; “The Food and Drug Administration (FDA) recognizes the extensive variety of actual and potential functions of mobile apps the rapid pace of innovation in mobile apps and the potential benefits and risks to public health represented by these apps. The FDA is issuing this guidance document to inform manufacturers distributors and other entities about how the FDA intends to apply its regulatory authorities to select software applications intended for use on mobile platforms (mobile applications or “mobile apps”). Given the rapid expansion and broad applicability of mobile apps the FDA is issuing this guidance document to clarify the subset of mobile apps to which the FDA intends to apply its authority. ”
